Denali Therapeutics(DNLI)
$18.74-0.15 (-0.79%)
DNLI
Denali Therapeutics earnings date
$18.74
At close:-0.15 (-0.79%)
Want to see DNLI full AI Analyst Report?
Denali Therapeutics (DNLI) Q2 2026 Earnings Report
895 Followers
DNLI Q2 2026 EPS Results
- Actual EPS
- -$0.68
- Consensus EPS
- -$0.51
- Beat/Miss
- Missed by -$0.17
- One Year Ago EPS
- -$0.72
DNLI Q2 2026 Revenue Results
- Actual Revenue
- $3.60M
- Expected Revenue
- $2.15M
- Beat/Miss
- Beat by +$1.45M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
DNLI Upcoming Earnings
Denali Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DNLI Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DNLI Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.61- | -0.73 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.270.37 | -0.74 | 150.00% (+1.11) | |
| Aug 06, 2026 | 2026 (Q2) | -0.51-0.68 | -0.72 | 5.56% (+0.04) | |
| May 07, 2026 | 2026 (Q1) | -0.72-0.69 | -0.78 | 11.54% (+0.09) | |
| Feb 26, 2026 | 2025 (Q4) | -0.74-0.73 | -0.67 | -8.96% (-0.06) | |
| Nov 06, 2025 | 2025 (Q3) | -0.75-0.74 | -0.63 | -17.46% (-0.11) | |
| Aug 11, 2025 | 2025 (Q2) | -0.71-0.72 | -0.59 | -22.03% (-0.13) | |
| May 06, 2025 | 2025 (Q1) | -0.70-0.78 | -0.68 | -14.71% (-0.10) | |
| Feb 27, 2025 | 2024 (Q4) | -0.80-0.67 | -0.86 | 22.09% (+0.19) | |
| Nov 06, 2024 | 2024 (Q3) | -0.59-0.63 | -0.72 | 12.50% (+0.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
